Advertisement
Singapore markets open in 13 minutes
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    64,674.16
    -2,042.48 (-3.06%)
     
  • CMC Crypto 200

    1,392.24
    -31.86 (-2.24%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Gold

    2,329.20
    -9.20 (-0.39%)
     
  • Crude Oil

    82.71
    -0.10 (-0.12%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    37,923.11
    -536.97 (-1.40%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    -7,110.81 (-49.78%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Venture acquires land site for $13m in Q2

Venture's Q3 profits surge 134.8% to $111.37m

It is in the heart of a high-tech industrial centre.

Venture Corporation has grown consistently for the last 15 quarters, but a move in the manufacturing supply chain could further boost its capacities.

It completed the acquisition of a 60-year leasehold land site for $13.0m in Q2 last year and paid $5.7m in 1H2016.

According to DBS Equity Research, development of the land is expected to start in 2017. It is located in the Batu Kawan Industrial park near Penang Island, well known for its high-tech electronics manufacturing industry.

DBS analyst Suvro Sarker commented, "Venture could benefit from specialised labour and improved supply chain networks with its presence in this area."

ADVERTISEMENT

Meanwhile, Venture could also benefit in the long run from the adoption of new enabling technologies and applications at the commercial level.

Venture has established strong relationships with companies researching on Genome sequencing, which could see healthy growth over the medium term with increasing investments and use of MedTech.

A firmer hold on lower-cost technologies in healthcare is also likely to boost its Test, Measurement, Medical and Life Science segment.

The segment contributed 43.2% to the top line in 2016 compared to 34% in 2015. This helped lift the company from the weak performance of its Computer Peripherals & Data Storage segment.



More From Singapore Business Review